Aedifica (WBO:AED) Beta: N/A (As of Jul. 12, 2026)

Name: Aedifica SA (AED) — Historical Annual & Quarterly Data
Creator: GuruFocus
License: https://www.gurufocus.com/terms-of-service.php

What is Aedifica Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-12), Aedifica's Beta is Not available.

Aedifica (WBO:AED) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Aedifica Beta Related Terms

Aedifica Beta Historical Data

* Premium members only.

The historical data trend for Aedifica's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aedifica Beta Chart

Aedifica Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Dec21

Dec22

Dec23

Dec24

Dec25

Beta

Get a 7-Day Free Trial

0.00

Aedifica Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Beta	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

83GF Score

Aedifica SA WBO:AED

Beta is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aedifica Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Aedifica (WBO:AED) Overvalued in 2026?

Based on GuruFocus' analysis, Aedifica stock appears to be undervalued. The current stock price of €69.60 is trading 5.2% below its estimated GF Value™ of €73.41.

Key valuation signals for WBO:AED:

Beta: N/A
GF Value™: €73.41 vs. price of €69.60 (5.2% below fair value)
GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the WBO:AED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aedifica Business Description

Industry Real Estate REITs

Comparable Companies XBRU:COFB XBRU:CPINV WELL VTR DOC OHI AHR CTRE HR TSX:CSH.UN SBRA NHI LSE:PHP MPT DHC SGX:C2PU LTC SILA NHP TSX:VITL.UN

Other Exchanges AEDb:UK 0DKX:UK AOO:Germany AED:Belgium

Address Rue Belliard 40 (box 11), Brussels, BEL, B-1040

Website https://www.aedifica.eu

Aedifica SA is a Belgian real estate investment trust that invests in, develops, and leases healthcare properties. The company focuses on providing housing for the aging population in Western Europe and the growing populations in Belgium's cities. The majority of Aedifica's real estate portfolio is composed of Elderly care homes. The company derives the vast majority of its income in the form of rental revenue. Its geographical segments are Belgium, Germany, Netherlands, Ireland, United Kingdom, Finland, and Sweden. Majority of revenue is from United Kingdom.

83GF Score

Get the complete analysis for WBO:AED

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.60

Price

€73.41

GF Value

View WBO:AED Analysis

See Beta data for all stocks →